Aventis Cites Plavix Patent Litigation In Countering Sanofi’s Takeover Bid

Apotex and Dr. Reddy's have raised a "substantial challenge" to the validity of Sanofi-Synthelabo's compound patent for Plavix, Aventis says in a Securities & Exchange Commission filing